A new clinical hope in cancer immunotherapy Paris, May 12th, 2015 – Invectys announces today that it has initiated a phase I clinical trial of its immunotherapeutic…
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G François Anna, Elodie Bole-Richard, Joel LeMaoult, Marie Escande, Martin Lecomte,…
